Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial

被引:9
|
作者
Wang Z. [1 ,2 ]
Wang R. [3 ]
Xiang S. [3 ]
Gu Y. [4 ]
Xu T. [3 ]
Jin H. [3 ]
Gu X. [3 ]
Tong P. [5 ]
Zhan H. [1 ,2 ]
Lv S. [5 ]
机构
[1] Shi’s Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai
[2] Institute of Traumatology and Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai
[3] Zhejiang Chinese Medical University, Zhejiang, Hangzhou
[4] Zhangjiagang TCM Hospital, Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu
[5] The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Zhejiang, Hangzhou
关键词
hyaluronic acid; intra-articular injection; knee; osteoarthritis; platelet-rich plasma;
D O I
10.3389/fbioe.2022.1062371
中图分类号
学科分类号
摘要
Background: Knee osteoarthritis (KOA) can be effectively treated conservatively using platelet-rich plasma (PRP) injections into the affected joints. While the short-term therapeutic clinical benefits were well documented, the mid-term results remain undetermined. To clarify its efficacy, the mid-term clinical outcomes of intra-articular injections of either PRP or hyaluronic acid (HA) in KOA were compared. Methods: One hundred patients who complied with the inclusion criteria were randomized to undergo once a week 3 weeks, intra-articular injections of either PRP or HA. Patients were evaluated before the injection, at 3, 6, and a mean of 78.9 months of follow-up. Eighty-five patients reached the final evaluation. Data on survival, re-intervention, pain, function, imaging, and satisfaction were collected and analyzed. Results: With surgery for any reason as the endpoint, the cumulative survival rate of the PRP group was 90%, while that of the HA group was 74%. There was a significant difference between the two groups in the total re-intervention rate (56.7% vs 16.2%, p < 0.05). The comparative analyses showed significant intergroup differences in the visual analog scale (VAS) and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) (p < 0.01, p < 0.05, respectively) at the final follow-up. And base on the regression analyses, the type of treatment, age, and Kellgren-Lawrence (K-L) grade served as statistically an independent determinants of VAS (p < 0.001, p = 0.034, p < 0.001, respectively). Likewise, those variables independently determined WOMAC in our study. However, no difference was observed in the imaging evaluation, containing the K-L grade and Cartilage Lesion Score, between the two groups (p > 0.05). Besides, the satisfaction treated by the PRP was 78.6%, with a superiority compared with HA (55.8%, p < 0.05), and no complications were noted in the whole treatment process among patients who participated. Conclusion: PRP was more effective than HA in survival and re-intervention rates, VAS, and WOMAC, although there were no significant differences in the imaging evaluation between the two groups. Furthermore, patients treated with PRP were associated with higher satisfaction compared with HA. Copyright © 2022 Wang, Wang, Xiang, Gu, Xu, Jin, Gu, Tong, Zhan and Lv.
引用
收藏
相关论文
共 50 条
  • [31] Autologous microfragmented adipose tissue and leukocyte-poor platelet-rich plasma combined with hyaluronic acid show comparable clinical outcomes for symptomatic early knee osteoarthritis over a two-year follow-up period: a prospective randomized clinical trial
    Alberto Gobbi
    Ignacio Dallo
    Riccardo D’Ambrosi
    European Journal of Orthopaedic Surgery & Traumatology, 2023, 33 : 1895 - 1904
  • [32] Autologous microfragmented adipose tissue and leukocyte-poor platelet-rich plasma combined with hyaluronic acid show comparable clinical outcomes for symptomatic early knee osteoarthritis over a two-year follow-up period: a prospective randomized clinical trial
    Gobbi, Alberto
    Dallo, Ignacio
    D'Ambrosi, Riccardo
    EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY, 2023, 33 (05): : 1895 - 1904
  • [33] One-Year Follow-up of Platelet-Rich Plasma Treatment in Chronic Achilles Tendinopathy A Double-Blind Randomized Placebo-Controlled Trial
    de Jonge, Suzan
    de Vos, Robert J.
    Weir, Adam
    van Schie, Hans T. M.
    Bierma-Zeinstra, Sita M. A.
    Verhaar, Jan A. N.
    Weinans, Harrie
    Tol, Johannes L.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2011, 39 (08): : 1623 - 1629
  • [34] Leucocyte-Rich Platelet-Rich Plasma Treatment of Gluteus Medius and Minimus Tendinopathy A Double-Blind Randomized Controlled Trial With 2-Year Follow-up
    Fitzpatrick, Jane
    Bulsara, Max K.
    O'Donnell, John
    Zheng, Ming Hao
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2019, 47 (05): : 1130 - 1137
  • [35] Platelet-Rich Plasma in Arthroscopic Rotator Cuff Repair: Clinical and Radiological Results of a Prospective Randomized Controlled Trial Study at 10-Year Follow-Up
    Randelli, Pietro Simone
    Stoppani, Carlo Alberto
    Santarsiero, Gianvito
    Nocerino, Elisabetta
    Menon, Alessandra
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2022, 38 (01): : 51 - 61
  • [36] Subacromial injection of platelet-rich plasma provides greater improvement in pain and functional outcomes compared to corticosteroids at 1-year follow-up: a double-blinded randomized controlled trial
    Rossi, Luciano Andres
    Brandariz, Rodrigo
    Gorodischer, Tomas
    Camino, Pablo
    Piuzzi, Nicolas
    Tanoira, Ignacio
    Ranalletta, Maximiliano
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2024, 33 (12) : 2563 - 2571
  • [37] Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial
    Bruyere, Olivier
    Honvo, Germain
    Vidovic, Eduard
    Cortet, Bernard
    BIOMOLECULES, 2021, 11 (10)
  • [38] Intra-Articular Leukocyte-Rich Platelet-Rich Plasma versus Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis: A Meta-Analysis of 14 Randomized Controlled Trials
    Peng, Yu-Ning
    Chen, Jean-Lon
    Hsu, Chih-Chin
    Chen, Carl P. C.
    Suputtitada, Areerat
    PHARMACEUTICALS, 2022, 15 (08)
  • [39] Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis
    Cole, Brian J.
    Karas, Vasili
    Hussey, Kristen
    Pilz, Kyle
    Fortier, Lisa A.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2017, 45 (02): : 339 - 346
  • [40] Clinical therapy of platelet-rich plasma vs hyaluronic acid injections in patients with knee osteoarthritis A systematic review and meta-analysis of randomized double-blind controlled trials
    Gong, Hao
    Li, Kaiming
    Xie, Rui
    Du, Guoqing
    Li, Linghui
    Wang, Shangquan
    Yin, Jing
    Gu, Jinyu
    Wang, Ping
    Chen, Ming
    Hou, Xiaozhou
    MEDICINE, 2021, 100 (12) : E25168